ArticleUrology case reports2026
A rare case of successful treatmeat of xanthogranulomatous prostatitis and literature reviews.
Article in Urology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Drug- and patient-specific neurological risk profiles of α1-adrenergic blockers: evidence from FAERS and external validation in JADER.Therapeutic advances in drug safety · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Xanthogranulomatous prostatitis (XGP) is extremely rare, and its clinical symptoms or imaging findings are difficult to distinguish from those of prostate cancer. This patient presented clinically with severe urinary tract infection and urinary tract obstruction, firstly he was initially treated with antibiotics. Through conservative treatments such as anti-inflammatory and symptomatic therapies, the patient's symptoms and indicators were controlled, and the PSA value decreased to 3.4ng/ml. For patients with significant clinical inflammatory indicators, elevated PSA levels, and high MRI PI-RADS scores, the possibility of XGP should be first excluded to avoid misdiagnosis and overtreatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.